Activity-based anorexia in C57/BL6 mice: Effects of the phytocannabinoid, △9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2

European Neuropsychopharmacology

Volumn 20, Issue 9, 2010, Pages 622-631

  Lewis, David Y ^a   Brett, Ros R ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Activity based anorexia; Anorexia nervosa; Mice; OMDM 2; Tetrahydrocannabinol

Indexed keywords

ANANDAMIDE; CANNABINOID DERIVATIVE; DRONABINOL; N OLEOYL (1' HYDROXYBENZYL) 2' ETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIET RESTRICTION; MALE; MOUSE; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SURVIVAL; WEIGHT REDUCTION;

EID: 77955096966     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.04.002     Document Type: Article

References (65)

1. Abe H., Kida M., Tsuji K., Mano T. Feeding cycles entrain circadian rhythms of locomotor activity in CS mice but not in C57BL/6J mice. Physiol. Behav. 1989, 45:397-401.
2. Atchley D.P., Eckel L.A. Fenfluramine treatment in female rats accelerates the weight loss associated with activity-based anorexia. Pharmacol. Biochem. Behav. 2005, 80:273-279.
3. Avraham Y., Hao S., Mendelson S., Berry E.M. Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia. Med. Sci. Sports Exerc. 2001, 33:2104-2110.
4. Avraham Y., Ben Shushan D., Breuer A., Zolotarev O., Okon A., Fink N., Katz V., Berry E.M. Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol Biochem Behav. 2004, 77:675-684.
5. Avraham Y., Menachem A.B., Okun A., Zlotarav O., Abel N., Mechoulam R., Berry E.M. Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res. Bull. 2005, 65:117-123.
6. Boakes R.A., Dwyer D.M. Weight loss in rats produced by running: effects of prior experience and individual housing. Q. J. Exp. Psychol. B 1997, 50:129-148.
7. Boer D.P., Epling W.F., Pierce W.D., Russell J.C. Suppression of food deprivation-induced high-rate wheel running in rats. Physiol. Behav. 1990, 48:339-342.
8. Challet E., Solberg L.C., Turek F.W. Entrainment in calorie-restricted mice: conflicting zeitgebers and free-running conditions. Am. J. Physiol. 1998, 274:R1751-R1761.
9. Cornish E.R., Mrosovsky N. Activity during food deprivation and satiation of six species of rodent. Anim. Behav. 1965, 13:242-248.
10. Court J., Carr-Gregg M., Bergh C., Brodin U., Callmar M., Ejderhamn J., Sodersten P. An innovative treatment programme for anorexia nervosa. J. Paediatr. Child Health 2005, 41:305-306.
11. de Lago E., Ligresti A., Ortar G., Morera E., Cabranes A., Pryce G., Bifulco M., Baker D., Fernandez-Ruiz J., Di Marzo V. In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. Eur. J. Pharmacol. 2004, 484:249-257.
12. de Lago E., Petrosino S., Valenti M., Morera E., Ortega-Gutierrez S., Fernandez-Ruiz J., Di Marzo V. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. Biochem Pharmacol 2005, 70:446-452.
13. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825.
14. Dixon D.P., Ackert A.M., Eckel L.A. Development of, and recovery from, activity-based anorexia in female rats. Physiol. Behav. 2003, 80:273-279.
15. Epling W.F., Pierce D., Stefan L. A theory of activity-based anorexia. Int. J. Eat. Disord. 1983, 3:26-46.
16. Exner C., Hebebrand J., Remschmidt H., Wewetzer C., Ziegler A., Herpertz S., Schweiger U., Blum W.F., Preibisch G., Heldmaier G., Klingenspor M. Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa. Mol. Psychiatry 2000, 5:476-481.
17. Frieling H., Albrecht H., Jedtberg S., Gozner A., Lenz B., Wilhelm J., Hillemacher T., de Zwaan M., Kornhuber J., Bleich S. Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders. Psychoneuroendocrinology 2009, 34:620-624.
18. Fu J., Gaetani S., Oveisi F., Lo V.J., Serrano A., Rodriguez D.F., Rosengarth A., Luecke H., Di Giacomo B., Tarzia G., Piomelli D. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 2003, 425:90-93.
19. Gelegen C., Collier D.A., Campbell I.C., Oppelaar H., Kas M.J. Behavioral, physiological, and molecular differences in response to dietary restriction in three inbred mouse strains. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E574-E581.
20. Gelegen C., Collier D.A., Campbell I.C., Oppelaar H., van den H.J., Adan R.A., Kas M.J. Difference in susceptibility to activity-based anorexia in two inbred strains of mice. Eur. Neuropsychopharmacol. 2007, 17:199-205.
21. Gelegen C., van den H.J., Collier D.A., Campbell I.C., Oppelaar H., Hessel E., Kas M.J. Dopaminergic and brain-derived neurotrophic factor signalling in inbred mice exposed to a restricted feeding schedule. Genes Brain Behav. 2008, 7:552-559.
22. Gordon C.J. Thermal biology of the laboratory rat. Physiol. Behav. 1990, 47:963-991.
23. Gross H., Ebert M.H., Faden V.B., Goldberg S.C., Kaye W.H., Caine E.D., Hawks R., Zinberg N. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J. Clin. Psychopharmacol. 1983, 3:165-171.
24. Gull W.W. Anorexia nervosa (apepsia hysterica, anorexia hysterica). Trans. Clin. Soc. Lond. 1874, 7:22-28.
25. Gutierrez E., Vazquez R. Heat in the treatment of patients with anorexia nervosa. Eat. Weight Disord. 2001, 6:49-52.
26. Gutierrez E., Vazquez R., Boakes R.A. Activity-based anorexia: ambient temperature has been a neglected factor. Psychon. Bull. Rev. 2002, 9:239-249.
27. Haney M., Ward A.S., Comer S.D., Foltin R.W., Fischman M.W. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl) 1999, 141:385-394.
28. Hanus L., Avraham Y., Ben Shushan D., Zolotarev O., Berry E.M., Mechoulam R. Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. Brain Res. 2003, 983:144-151.
29. Hao S., Avraham Y., Mechoulam R., Berry E.M. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur. J. Pharmacol. 2000, 392:147-156.
30. Hartman D. Anorexia nervosa-diagnosis, aetiology, and treatment. Postgrad. Med. J. 1995, 71:712-716.
31. Hebebrand J., van der, H.J., Devos R., Kopp W., Herpertz S., Remschmidt H., Herzog W. Plasma concentrations of obese protein in anorexia nervosa. Lancet 1995, 346:1624-1625.
32. Hebebrand J., Exner C., Hebebrand K., Holtkamp C., Casper R.C., Remschmidt H., Herpertz-Dahlmann B., Klingenspor M. Hyperactivity in patients with anorexia nervosa and in semistarved rats: evidence for a pivotal role of hypoleptinemia. Physiol. Behav. 2003, 79:25-37.
33. Hillebrand J.J., Koeners M.P., de Rijke C.E., Kas M.J., Adan R.A. Leptin treatment in activity-based anorexia. Biol. Psychiatry 2005, 58:165-171.
34. Hillebrand J.J., Kas M.J., Scheurink A.J., van Dijk G., Adan R.A. AgRP(83-132) and SHU9119 differently affect activity-based anorexia. Eur. Neuropsychopharmacol. 2006, 16:403-412.
35. Kaye W.H., Klump K.L., Frank G.K., Strober M. Anorexia and bulimia nervosa. Annu. Rev. Med. 2000, 51:299-313.
36. Lacey J.H., Crisp A.H., Kalucy R.S., Hartmann M., Chien C. Study of EEG sleep characteristics in patients with anorexia nervosa before and after restoration of matched population mean weight consequent on ingestion of a "normal" diet. Postgrad. Med. J. 1976, 52:45-49.
37. Lauer C.J., Krieg J.C. Weight gain and all-night EEG-sleep in anorexia nervosa. Biol. Psychiatry 1992, 31:622-625.
38. Lauer C.J., Krieg J.C. Sleep in eating disorders. Sleep Med. Rev. 2004, 8:109-118.
39. Lett B.T., Grant V.L., Koh M.T., Parsons J.F. Chlordiazepoxide attenuates activity-induced anorexia and weight loss in rats. Exp. Clin. Psychopharmacol. 1998, 6:360-366.
40. Matias I., Leonhardt M., Lesage J., De Petrocellis L., Dupouy J.P., Vieau D., Di Marzo V. Effect of maternal under-nutrition on pup body weight and hypothalamic endocannabinoid levels. Cell. Mol. Life Sci. 2003, 60:382-389.
41. Mattes R.D., Engelman K., Shaw L.M., Elsohly M.A. Cannabinoids and appetite stimulation. Pharmacol. Biochem. Behav. 1994, 49:187-195.
42. Miller K.K., Grinspoon S.K., Ciampa J., Hier J., Herzog D., Klibanski A. Medical findings in outpatients with anorexia nervosa. Arch. Intern. Med. 2005, 165:561-566.
43. Mistlberger R.E. Circadian food-anticipatory activity: formal models and physiological mechanisms. Neurosci. Biobehav. Rev. 1994, 18:171-195.
44. Monteleone P., Matias I., Martiadis V., De Petrocellis L., Maj M., Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 2005, 30:1216-1221.
45. Morrow N.S., Schall M., Grijalva C.V., Geiselman P.J., Garrick T., Nuccion S., Novin D. Body temperature and wheel running predict survival times in rats exposed to activity-stress. Physiol. Behav. 1997, 62:815-825.
46. Ortar G., Ligresti A., De Petrocellis L., Morera E., Di Marzo V. Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem. Pharmacol. 2003, 65:1473-1481.
47. Overton J.M., Williams T.D. Behavioral and physiologic responses to caloric restriction in mice. Physiol. Behav. 2004, 81:749-754.
48. Pare W.P. The influence of food consumption and running activity on the activity-stress ulcer in the rat. Am. J. Dig. Dis. 1975, 20:262-273.
49. Pertwee R.G., Tavendale R. Effects of delta9-tetrahydrocannabinol on the rates of oxygen consumption of mice. Br. J. Pharmacol. 1977, 60:559-568.
50. Rahminiwati M., Nishimura M. Effects of delta 9-tetrahydrocannabinol and diazepam on feeding behavior in mice. J. Vet. Med. Sci. 1999, 61:351-355.
51. Rikke B.A., Yerg J.E., Battaglia M.E., Nagy T.R., Allison D.B., Johnson T.E. Strain variation in the response of body temperature to dietary restriction. Mech. Ageing Dev. 2003, 124:663-678.
52. Routtenberg A., Kuznesof A.W. Self-starvation of rats living in activity wheels on a restricted feeding schedule. J. Comp. Physiol. Psychol. 1967, 64:414-421.
53. Russell J.C., Epling W.F., Pierce D., Amy R.M., Boer D.P. Induction of voluntary prolonged running by rats. J. Appl. Physiol. 1987, 63:2549-2553.
54. Sanudo-Pena M.C., Romero J., Seale G.E., Fernandez-Ruiz J.J., Walker J.M. Activational role of cannabinoids on movement. Eur. J. Pharmacol. 2000, 391:269-274.
55. Siegfried Z., Berry E.M., Hao S., Avraham Y. Animal models in the investigation of anorexia. Physiol. Behav. 2003, 79:39-45.
56. Siegfried Z., Kanyas K., Latzer Y., Karni O., Bloch M., Lerer B., Berry E.M. Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 125:126-130.
57. Soria-Gomez E., Matias I., Rueda-Orozco P.E., Cisneros M., Petrosino S., Navarro L., Di Marzo V., Prospero-Garcia O. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. Br. J. Pharmacol. 2007, 151:1109-1116.
58. Sparling P.B., Giuffrida A., Piomelli D., Rosskopf L., Dietrich A. Exercise activates the endocannabinoid system. Neuroreport 2003, 14:2209-2211.
59. Steinhausen H.C. The outcome of anorexia nervosa in the 20th century. Am. J. Psychiatry 2002, 159:1284-1293.
60. Verhagen L.A., Luijendijk M.C., Hillebrand J.J., Adan R.A. Dopamine antagonism inhibits anorectic behavior in an animal model for anorexia nervosa. Eur. Neuropsychopharmacol. 2009, 19:153-160.
61. Wilckens T., Schweiger U., Pirke K.M. Activation of 5-HT1C-receptors suppresses excessive wheel running induced by semi-starvation in the rat. Psychopharmacology (Berl) 1992, 109:77-84.
62. Wilckens T., Schweiger U., Pirke K.M. Activation of alpha 2-adrenoceptors suppresses excessive wheel running in the semistarvation-induced hyperactive rat. Pharmacol. Biochem. Behav. 1992, 43:733-738.
63. Wiley J.L., Burston J.J., Leggett D.C., Alekseeva O.O., Razdan R.K., Mahadevan A., Martin B.R. CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br. J. Pharmacol. 2005, 145:293-300.
64. Williams C.M., Rogers P.J., Kirkham T.C. Hyperphagia in pre-fed rats following oral delta9-THC. Physiol. Behav. 1998, 65:343-346.
65. Williams T.D., Chambers J.B., Henderson R.P., Rashotte M.E., Overton J.M. Cardiovascular responses to caloric restriction and thermoneutrality in C57BL/6J mice. Am. J. Physiol. Regul. Integr.Comp. Physiol. 2002, 282:R1459-R1467.